Λίστα αντικειμένων
We discussed and we adapted the following protocol
BBMT 2018
Stem cell mobilization was achieved using granulocyte colony-stimulating
factor (G-CSF) at 10 to16 μg/kg/day for 3 to 4 days after dialysis on
dialysis days
Melphalan was dosed at 70 to 200 mg/m2 divided over2 days (days -3 and
-2 based on the patient’s age,severity of cardiac involvement, and
performance status.
Hemodialysis was planned on day 0 for no earlier than2 hours after
melphalan administration, usually on day -2
Adapted in our clinic
mobilization: G-CSF) at 10 to16 μg/kg/day for 4 days after dialysis on
dialysis day
Day -3 Dialysis
day -2 on apheresis, Meplahalan 110 = fluidics (cave)
day0 dialysis and than infusion
day1 dialysis
Participants: Dr Liga, Dr Spyridis, Dr Lekka, Dr Kostopoulou
BBMT 2018
Stem cell mobilization was achieved using granulocyte colony-stimulating
factor (G-CSF) at 10 to16 μg/kg/day for 3 to 4 days after dialysis on
dialysis days
Melphalan was dosed at 70 to 200 mg/m2 divided over2 days (days -3 and
-2 based on the patient’s age,severity of cardiac involvement, and
performance status.
Hemodialysis was planned on day 0 for no earlier than2 hours after
melphalan administration, usually on day -2
Adapted in our clinic
mobilization: G-CSF) at 10 to16 μg/kg/day for 4 days after dialysis on
dialysis day
Day -3 Dialysis
day -2 on apheresis, Meplahalan 110 = fluidics (cave)
day0 dialysis and than infusion
day1 dialysis
Participants: Dr Liga, Dr Spyridis, Dr Lekka, Dr Kostopoulou